Celon Pharma SA's total assets for Q2 2025 were zł482.63M, a decrease of -7.65% from the previous quarter. PL:CLN total liabilities were zł97.52M for the fiscal quarter, a -5.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.